title: Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog.
authors.affiliation: Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zürich, Winterthurerstr, Switzerland. ezini@vetclinics.unizh.ch
authors.forename: Eric
authors.initials: E
authors.lastname: Zini
authors.forename: Tony M
authors.initials: TM
authors.lastname: Glaus
authors.forename: Francesco
authors.initials: F
authors.lastname: Minuto
authors.forename: Marica
authors.initials: M
authors.lastname: Arvigo
authors.forename: Beat
authors.initials: B
authors.lastname: Hauser
authors.forename: Claudia E
authors.initials: CE
authors.lastname: Reusch
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000662:veterinary*; D004283:Dog Diseases / Q000378:metabolism*; D004285:Dogs; D005260:Female; D007003:Hypoglycemia / Q000209:etiology / Q000662:veterinary*; D007335:Insulin-Like Growth Factor II / Q000378:metabolism*; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D007335:Insulin-Like Growth Factor II; D011241:Prednisone